Skip to main content

Funding Opportunities and Announcements

CFAR Adelante:

The National Institutes of Health released a RFA, CFAR Adelante, for mentorship for new HIV/AIDS investigators to meet the needs of Hispanic/Latino communities. The program is funded by NIH/NIMHD, and it is administered by two Centers for AIDS Research: DC CFAR and Emory University CFAR. Concept proposals are due January 11, 2021. Visit the CFAR Adelante websiteSee the program fact sheet for an overview (PDF). The full RFA is here (PDF).

 

HIV/AIDS Community Information Outreach Program (ACIOP) Competitive Awards:

The National Library of Medicine is pleased to announce the 2021 solicitation of proposals from organizations and libraries to design and conduct projects that will improve access to HIV/AIDS related health information for patients, the affected community, and their caregivers. Application deadline is December 28 2:00 PM ET. Learn more and apply: https://www.orau.gov/hsc/nlm/aciop/

 

Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional) Applications are due January 11, 2021. 

 

Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional) Applications are due January 11, 2021. 

 

Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)

 

Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) Opens Dec. 15, 2020.

 

Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) Opens Dec. 15, 2020.

 

Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) Opens Dec. 15, 2020.

 

Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) Opens February 17, 2021.

 

Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) Opens Dec. 15, 2020.

 

Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) Earliest submission date December 7, 2020. 

 

New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)

 

Four New Funding Opportunities, Rapid Acceleration of Diagnostics (RADX) Related to COVID-19 Testing

 

Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)  

 

NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) Posted August 17, 2020; open for applications Feb. 26, 2021.

 

Advancing HIV/AIDS Research within the Mission of the NIDCD (two opportunities), standard AIDS dates apply. Expires in 2023.

R21 Clinical Trial Optional

R01 Clinical Trial Optional

 

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) Application due dates in December 2020 and March 2021. 

 

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) Application due date Dec. 1, 2020.

 

Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) First available due date Jan. 31, 2020.

 

Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)

 

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities

 

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

 

NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)

 

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

 

Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 Expires Dec. 30, 2020

 

Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional) 

 

Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions 

 

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

 

HIV/AIDS High Priority Drug Abuse Research 

 

Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults Expires Jan. 8, 2021

 

Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities Expires Jan. 8, 2021

 

Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation Expires May 8, 2021.

 

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) 

 

Centers for AIDS Research (P30 Clinical Trial Not Allowed) 

 

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)